Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-15

Clinical Trial Update: Bupivacaine and Epinephrine Injection Study [Phase 2, Phase 3]

View source ↗

Summary

The document provides an update on a Phase 2/3 clinical trial evaluating injections of bupivacaine with epinephrine for sinus disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • EPINEPHRINE (EPINEPHRINE)

Snippet

Sponsor: Amin Javer | Conditions: Sinus Disease, Anesthesia | Phase 2, Phase 3 | Status: RECRUITING